Dr Kelsey Zhongling, deputy executive director of ImmunoDiagnostics (second from right), and the company’s research team Dr Kelsey Zhongling, deputy executive director of ImmunoDiagnostics (second from right), and the company’s research team
Dr Kelsey Zhongling, deputy executive director of ImmunoDiagnostics (second from right), and the company’s research team

GBA injects new impetus to biotech start-ups

Dr Kelsey Zhongling, deputy executive director of ImmunoDiagnostics (second from right), and the company’s research team Dr Kelsey Zhongling, deputy executive director of ImmunoDiagnostics (second from right), and the company’s research team
Dr Kelsey Zhongling, deputy executive director of ImmunoDiagnostics (second from right), and the company’s research team
READ FULL ARTICLE